Shioko Kimura

The human CYP2F gene subfamily: identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression, and chromosome mapping.

C. Kozak, O. Mcbride, F. Gonzalez, 1990, Biochemistry.

Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2.

T. Pineau, F. Gonzalez, B. Tang, 1996, Pharmacogenetics.

The human CYP2D locus associated with a common genetic defect in drug oxidation: a G1934----A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recognition site.

U. Meyer, F. Gonzalez, N. Hanioka, 1990, American journal of human genetics.

The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.

R. Skoda, U. Meyer, F. Gonzalez, 1989, American journal of human genetics.

Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice.

F. Gonzalez, S. Kimura, Shioko Kimura, 2001, Mutation research.

Role of gene knockout mice in understanding the mechanisms of chemical toxicity and carcinogenesis.

F. Gonzalez, S. Kimura, Shioko Kimura, 1999, Cancer letters.

Role of CYP1A2 in the toxicity of long-term phenacetin feeding in mice.

J. Ward, J. Peters, F. Gonzalez, 1999, Toxicological sciences : an official journal of the Society of Toxicology.

Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression.

D. Nebert, A. Jaiswal, R. Owens, 1989, Molecular endocrinology.

Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.

F. Gonzalez, S. Kimura, J. Corchero, 2001, Pharmacogenetics.